Identification of Symptom-Specific Brain Circuit Abnormalities in Obsessive-Compulsive Disorder
September 01, 2022 08:00 ET
|
Brain & Behavior Research Foundation
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Identification of Symptom-Specific Brain Circuit Abnormalities in...
OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response - A Free Webinar from the Brain & Behavior Research Foundation
December 07, 2021 09:00 ET
|
Brain & Behavior Research Foundation
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response”...
Deep Brain Stimulation Systems Market Size Worth USD 2,122.8 Million in 2027 | Rising Demand for Painless and Wireless Stimulation Systems and Rapid Technological Advancements are Key Factors Driving Industry Growth, says Emergen Research
April 06, 2021 04:33 ET
|
Emergen Research
Vancouver, British Columbia, April 06, 2021 (GLOBE NEWSWIRE) -- The global deep brain stimulation systems market size is expected to reach USD 2,122.8 Million in 2027 at a CAGR of 8.1% during the...
An OCD survivor shares principles, tools and insight to help sufferers of OCD choose recovery over fear and get better
March 11, 2021 01:38 ET
|
Balboa Press
DALE CITY, Va., March 11, 2021 (GLOBE NEWSWIRE) -- Shannon Shy was diagnosed with a severe case of obsessive-compulsive disorder while on active duty in the Marine Corps. He finally sought help...
BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session
October 06, 2020 09:00 ET
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
Antidepressant Drugs Market to Grow Valuation of $15.98 Billion by 2023
August 06, 2020 10:15 ET
|
Allied Market Research
Portland, OR, Aug. 06, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research,the antidepressant drugs market accounted for $13.75 billion in 2016, and is estimated to...
Solace Behavioral Health Clinic Hosts Grand Opening to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
February 20, 2020 09:00 ET
|
Solace Behavioral Health
TAMPA, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Solace Behavioral Health, a mental health clinic offering advanced treatments for mental health disorders, announced today that it will host an grand...
Achieve TMS East Celebrates the Opening of a New Office in Glastonbury, CT
January 23, 2020 09:00 ET
|
Achieve TMS East
GLASTONBURY, Conn., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Achieve TMS East, New England’s largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of depression...
Empower Psychiatry & Sleep LLC Now Offers New Treatment for Major Depressive Disorder (MDD)
December 03, 2019 09:00 ET
|
Empower Psychiatry & Sleep LLC
SUWANEE, Ga., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Empower Psychiatry & Sleep LLC, a mental health clinic dedicated to serving its community with safe and effective treatments, today announced...
TMS Program Hosts Open House to Introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
November 12, 2019 09:00 ET
|
TMS Program
CHERRY HILL, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- TMS Program, a mental health clinic that provides treatments to a wide range of psychiatric disorders, today announced that it will host an open...